GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease
- 27 November 2006
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 412 (3) , 259-263
- https://doi.org/10.1016/j.neulet.2006.11.017
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson’s diseaseNeuroscience, 2006
- GDNF Delivery Using Human Neural Progenitor Cells in a Rat Model of ALSHuman Gene Therapy, 2005
- Ubiquitin–proteasome system and Parkinson's diseasesExperimental Neurology, 2004
- A neuroprotective role of glial cell line-derived neurotrophic factor following moderate spinal cord contusion injuryExperimental Neurology, 2004
- Effects of GDNF on 6‐OHDA‐induced death in a dopaminergic cell line: Modulation by inhibitors of PI3 kinase and MEKJournal of Neuroscience Research, 2003
- Importance of individuality in oxidative stress and aging 1,2 1Guest Editor: Rajindar S. Sohal 2This article is part of a series of reviews on “Oxidative Stress and Aging.” The full list of papers may be found on the homepage of the journal.Free Radical Biology & Medicine, 2002
- Gene transfer of glial cell‐derived neurotrophic factor and cardiotrophin‐1 protects PC12 cells from injury: Involvement of the phosphatidylinositol 3‐kinase and mitogen‐activated protein kinase kinase pathwaysJournal of Neuroscience Research, 2002
- Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patientsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2001
- Cell death mechanisms in Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2000
- Functional recovery in parkinsonian monkeys treated with GDNFNature, 1996